192 related articles for article (PubMed ID: 22886784)
1. Recent advances in proteomic technologies applied to cardiovascular disease.
Napoli C; Zullo A; Picascia A; Infante T; Mancini FP
J Cell Biochem; 2013 Jan; 114(1):7-20. PubMed ID: 22886784
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
3. Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation.
Percy AJ; Byrns S; Chambers AG; Borchers CH
Expert Rev Proteomics; 2013 Dec; 10(6):567-78. PubMed ID: 24206229
[TBL] [Abstract][Full Text] [Related]
4. Urinary proteomics in cardiovascular disease: Achievements, limits and hopes.
Delles C; Diez J; Dominiczak AF
Proteomics Clin Appl; 2011 Jun; 5(5-6):222-32. PubMed ID: 21523916
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in capillary electrophoresis-based proteomic techniques for biomarker discovery.
Fang X; Balgley BM; Lee CS
Electrophoresis; 2009 Dec; 30(23):3998-4007. PubMed ID: 19960464
[TBL] [Abstract][Full Text] [Related]
6. Clinical application of urinary proteomics/peptidomics.
Albalat A; Mischak H; Mullen W
Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
[TBL] [Abstract][Full Text] [Related]
7. Role of proteomics in the discovery of autism biomarkers.
Al-Ayadhi L; Halepoto DM
J Coll Physicians Surg Pak; 2013 Feb; 23(2):137-43. PubMed ID: 23374519
[TBL] [Abstract][Full Text] [Related]
8. 2D gel electrophoresis and mass spectrometry identification and analysis of proteins.
Meleady P
Methods Mol Biol; 2011; 784():123-37. PubMed ID: 21898217
[TBL] [Abstract][Full Text] [Related]
9. Capillary electrophoresis coupled to mass spectrometry for proteomic profiling of human urine and biomarker discovery.
Zürbig P; Schiffer E; Mischak H
Methods Mol Biol; 2009; 564():105-21. PubMed ID: 19544019
[TBL] [Abstract][Full Text] [Related]
10. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes.
Fliser D; Wittke S; Mischak H
Electrophoresis; 2005 Jul; 26(14):2708-16. PubMed ID: 15966014
[TBL] [Abstract][Full Text] [Related]
11. Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes.
Roe MR; Griffin TJ
Proteomics; 2006 Sep; 6(17):4678-87. PubMed ID: 16888762
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins.
Boja ES; Rodriguez H
Proteomics; 2012 Apr; 12(8):1093-110. PubMed ID: 22577011
[TBL] [Abstract][Full Text] [Related]
13. The molecular make-up of a tumour: proteomics in cancer research.
Kolch W; Mischak H; Pitt AR
Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
[TBL] [Abstract][Full Text] [Related]
14. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
Lee HJ; Lee EY; Kwon MS; Paik YK
Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
[TBL] [Abstract][Full Text] [Related]
15. Industrialized MS-based proteomics in the search for circulating biomarkers.
Migneault I; Hunter JM
Bioanalysis; 2009 Sep; 1(6):1149-63. PubMed ID: 21083081
[TBL] [Abstract][Full Text] [Related]
16. CE-MS in biomarker discovery, validation, and clinical application.
Mischak H; Schanstra JP
Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
[TBL] [Abstract][Full Text] [Related]
17. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry.
Meilhac O; Delbosc S; Michel JB
Methods Mol Biol; 2007; 357():331-41. PubMed ID: 17172699
[TBL] [Abstract][Full Text] [Related]
19. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
Schiffer E; Mischak H; Novak J
Proteomics; 2006 Oct; 6(20):5615-27. PubMed ID: 16991199
[TBL] [Abstract][Full Text] [Related]
20. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
Mischak H; Delles C; Klein J; Schanstra JP
Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
